eBanking Login

Candriam Equities L Oncology Impact R-H

206,49 EUR  -0,65 % (-1,35)
Verkaufen Kaufen

Candriam Equities L Oncology Impact R-H

WKN A2PA0P | ISIN LU1864483083 |  Fonds
Factsheet
17.09.24
206,49 EUR  -0,65 % (-1,35)
Candriam Equities L Oncology Impact V (thesaurierend) Candriam Equities L Oncology Impact PI (thesaurierend) Candriam Equities L Oncology Impact I (thesaurierend) Candriam Equities L Oncology Impact I (ausschüttend) Candriam Equities L Oncology Impact S-AH (ausschüttend) Candriam Equities L Oncology Impact I-H (thesaurierend) Candriam Equities L Oncology Impact, V - Capitalisation (thesaurierend) Candriam Equities L Oncology Impact C-H (thesaurierend) Candriam Equities L Oncology Impact C (thesaurierend) Candriam Equities L Oncology Impact C (ausschüttend) Candriam Equities L Oncology Impact R (ausschüttend) Candriam Equities L Oncology Impact R (thesaurierend) Candriam Equities L Oncology Impact R (thesaurierend) Candriam Equities L Oncology Impact N-H (thesaurierend) Candriam Equities L Oncology Impact R (thesaurierend) Candriam Equities L Oncology Impact R-H (thesaurierend) Candriam Equities L Oncology Impact I (thesaurierend) Candriam Equities L Oncology Impact, N - Capitalisation (thesaurierend) Candriam Equities L Oncology Impact C (thesaurierend)
Verkaufen
Kaufen
Name Aktuell Zeit Vortag Diff. % Diff. Vol. Stk.
Fonds 206,49 EUR 17.09.24 207,84 -0,65 % -1,35 -
Kaufen Verkaufen